Central Drugs Standard Control Organisation (CDSCO) Current Affairs - 2020

Japan approves Dexamethasone as COVID-19 Treatment

The Japanese Government recently approved Dexamethasone as a second treatment of COVID-19. The approval came in after Britain showed that the drug reduced death rates in COVID-19 patients. Highlights Dexamethasone has been approved for treatment along with Remdesivir. A clinical trial of UK proved that Dexamethasone as the first drug saved lives of COVID-19. India Read More…

Hetero’s injectable ‘Covifor’ gets DCGI approval for COVID-19 Treatment

For the treatment of COVID-19 positive cases, on 21st June 2020, Hyderabad based pharmaceutical company -Hetero Drugs has received approval from the Drug Controller General of India (a department under- CDSCO: Central Drugs Standard Control Organization) for manufacturing and marketing of antiviral drug Remdesivir. Brandname for Marketing Under the brand name ‘Covifor’, Hetero Pharmaceuticals’ generic Read More…

India’s First Oral Vaccine for Moderate COVID-19 Cases gets Approval

For the treatment of mild to moderate COVID-19 positive patients across the country, on 19th June 2020, for manufacturing and marketing of oral antiviral drug ‘Favipiravir (Fabiflu)’ was approved by the National Regulatory Authority for Indian pharmaceuticals -Central Drugs Standard Control Organisation (CDSCO) to Mumbai based Glenmark Pharmaceuticals. The approval for the drug was given Read More…